AAM: Reference Pricing Could Be Fix For Low Generic Reimbursement

By Rachel Cohrs / January 2, 2019 at 3:59 PM

The generic drug lobby sees expanding the use of international reference pricing as a potential opportunity to remedy low reimbursement rates for generic drugs, Association for Accessible Medicines President Chip Davis told Inside Health Policy.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.